Rocket Doctor AIAIRDF +0.50%29 PB Ratio is 9.36 as of Jun. 24, 2026, which is 22% above its 10-year median of 7.70. GuruFocus rates AIRDF with a GF Score™ of 29/100. The stock has 7 warning signs investors should review. Among 611 Healthcare Providers & Services companies, Rocket Doctor AI ranks worse than 93.62% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-06-24), Rocket Doctor AI's share price is $0.44. Rocket Doctor AI's Book Value per Share for the quarter that ended in Mar. 2026 was $0.05. Hence, Rocket Doctor AI's PB Ratio of today is 9.36.
The historical rank and industry rank for Rocket Doctor AI's PB Ratio or its related term are showing as below:
AIRDF'
s PB Ratio Range Over the Past 10 Years
Min: 3.55 Med: 7.7 Max: 20
Current: 8.8
During the past 7 years, Rocket Doctor AI's highest PB Ratio was 20.00. The lowest was 3.55. And the median was 7.70.
AIRDF's PB Ratio is ranked worse than 93.62% of 611
companies
in the Healthcare Providers & Services industry
Industry Median: 1.96
vs AIRDF: 8.80
During the past 12 months, Rocket Doctor AI's average Book Value Per Share Growth Rate was 62.50% per year.
During the past 7 years, the highest 3-Year average Book Value Per Share Growth Rate of Rocket Doctor AI was 21.30% per year. The lowest was -4.10% per year. And the median was 8.60% per year.
Back to Basics: PB Ratio
Rocket Doctor AI (OTCPK:AIRDF) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Rocket Doctor AI PB Ratio Related Terms
Rocket Doctor AI PB Ratio Historical Data
* Premium members only.
The historical data trend for Rocket Doctor AI's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Rocket Doctor AI's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Rocket Doctor AI PB Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Rocket Doctor AI's PB Ratio distribution charts can be found below:
* The bar in red indicates where Rocket Doctor AI's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Rocket Doctor AI (AIRDF) has a PB Ratio of 9.36 as of Jun. 24, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Rocket Doctor AI and its competitors. This is 22% above median its historical median of 7.70. Over the past decade, Rocket Doctor AI's PB Ratio has ranged from 3.55 to 20.00. According to the industry distribution chart, Rocket Doctor AI ranks #572 out of 611 companies in the Healthcare Providers & Services industry, placing it in the top 93.6%.
Is Rocket Doctor AI's PB Ratio too high?
Rocket Doctor AI's current PB Ratio of 9.36 is 22% above median its 10-year median of 7.70. Over the past 10 years, this metric has ranged from a low of 3.55 to a high of 20.00. The Healthcare Providers & Services industry median PB Ratio is 1.96. Rocket Doctor AI's value of 9.36 is 377.6% above this industry median. Based on the distribution chart, Rocket Doctor AI ranks #572 out of 611 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Rocket Doctor AI has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does Rocket Doctor AI's PB Ratio compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Rocket Doctor AI ranks #572 out of 611 companies for PB Ratio. This places Rocket Doctor AI in the lower half of its industry. The industry median PB Ratio is 1.96. Rocket Doctor AI's value of 9.36 is 377.6% above this benchmark. Historically, Rocket Doctor AI's own PB Ratio has ranged from 3.55 to 20.00 over the past decade. While the company's 10-year median is 7.70 vs. the industry median of 1.96, Rocket Doctor AI has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Healthcare Providers & Services company?
The median PB Ratio among Healthcare Providers & Services companies is 1.96, based on 611 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Rocket Doctor AI's current PB Ratio of 9.36 is 377.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Rocket Doctor AI and its competitors. For the Healthcare Providers & Services industry, the median PB Ratio is 1.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Rocket Doctor AI's current PB Ratio is 9.36, which is 22% above median its own 10-year median of 7.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rocket Doctor AI stock overvalued right now?
Rocket Doctor AI (AIRDF) has a current PB Ratio of 9.36. The current PB Ratio is 9.36, which is 22% above median its 10-year median of 7.70 and 377.6% above the Healthcare Providers & Services industry median of 1.96. Rocket Doctor AI's overall GF Score™ is 29/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Rocket Doctor AI (AIRDF), the current PB Ratio is 9.36 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Rocket Doctor AI Inc delivers physician-built, AI-powered solutions designed to make high-quality healthcare accessible throughout the entire patient journey. A cornerstone of the company's proprietary technology is the Global Library of Medicine (GLM), a clinically validated decision support system developed with input from hundreds of physicians world-wide. Alongside the GLM and its AI-powered digital health platform and marketplace. The group empowers over 300 MDs to provide care to more than 700,000 patients. Its proprietary technology software and systems enable doctors to independently launch and manage their own virtual or hybrid in-person practices - improving efficiency, restoring autonomy to MDs, and expanding patient access to care.
29GF Score
Get the complete analysis for AIRDF
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AIRDF has been successfully added to your 
